Category: 3. Business

  • New white paper lays groundwork for adaptation finance guide supporting ASEAN Taxonomy – United Nations Environment – Finance Initiative

    New white paper lays groundwork for adaptation finance guide supporting ASEAN Taxonomy – United Nations Environment – Finance Initiative

    Climate adaptation has emerged as one of the defining priorities of our time. Nowhere is this challenge more acute than in the ASEAN region, where climate-related risks—rising sea levels, floods, droughts, and extreme heat—threaten the foundations of economic stability, livelihoods, and ecosystems. Addressing these risks requires mobilizing enormous levels of finance—both public and private—and ensuring that investments are aligned with resilience outcomes.

    A new white paper, the first output from a collaboration among the ASEAN Capital Markets Forum (ACMF), Sustainable Finance Institute Asia (SFIA), and United Nations Environment Programme Finance Initiative (UNEP FI),* lays the groundwork for a forthcoming guide that aims to channel more finance towards building adaptation and resilience capacity in support of Environmental Objective (EO) 2 of the ASEAN Taxonomy for Sustainable Finance (ASEAN Taxonomy). The work is financially and technically supported by the European Union Sustainable Finance Advisory Hub (EUSFAH), which promotes interoperable and credible sustainable finance frameworks globally.

    The ASEAN Taxonomy is a valuable tool for governments and the private sector to identify economic activities in the region that support climate-positive outcomes and other sustainability goals—and in turn, to finance aligned activities. Taxonomies have proven instrumental in directing capital towards mitigation, but additional information to provide clear, sector-specific guidance for assessing what qualifies as an “adaptation-aligned” investment can enhance the orientation of capital towards adaptation. The additional guidance can be useful for financial institutions to identify, assess, and report on credible adaptation opportunities—promoting the flow of private finance into projects that build resilience.

    To address this, ACMF, chaired by SC Malaysia, in collaboration with UNEP FI, will develop a mitigation co-benefit and Adaptation for Resilience (mARs) Guide to serve as a companion to the ASEAN Taxonomy, providing the methodological foundation for identifying the key principles and sectoral priorities that can enhance the functionality and usability of the taxonomy to channel  adaptation finance.

    The new white paper marks the first phase of the collaboration among the EUSFAH, UNEP FI, ACMF, and SFIA to translate high-level objectives into practical guidance that financial institutions, regulators, and issuers can apply when identifying, assessing, and tracking adaptation-aligned investments, and aims to catalyze adaptation finance in the region.

    “The ACMF is committed to advancing sustainable finance in the region. The mARs Guide will complement the ASEAN Taxonomy by providing practical tools for adaptation finance, ensuring that our markets remain resilient and future-ready. This white paper outlines the key elements and considerations that will guide the development of the mARs Guide, and highlights the need to address the adaptation funding gap, through mechanisms such as blended finance, which is key to funding non-bankable but necessary projects.”

    – Dato’ Mohammad Faiz Azmi, Chairman of the Securities Commission Malaysia, the current Chair of the ACMF

    Strengthening adaptation finance in ASEAN

    The white paper highlights that adaptation finance remains significantly underfunded compared to mitigation, with current flows falling far short of the scale required to protect communities and markets. As detailed in UNEP’s latest Adaptation Gap Report, developing countries require between USD 310 billion and USD 365 billion annually by 2035 to meet climate adaptation needs, yet only approximately USD 26 billion was available from international public finance in 2023. Mobilizing both public and private capital toward resilience outcomes is therefore an urgent priority.

    Taxonomies play a critical role in mobilizing finance by providing a common language and classification system that helps investors, regulators, and issuers identify credible activities, including adaptation-aligned activities, and channel capital toward them with confidence. UNEP FI’s earlier analysis of ASEAN Member States’ sustainable finance taxonomies shows increasing alignment between domestic taxonomies and the regional ASEAN Taxonomy in areas such as climate change mitigation, adaptation, biodiversity, and circular economy priorities. The mARs Guide builds on this progress by offering the practical detail and sector-level guidance needed for financial institutions to integrate adaptation criteria into investment decisions, product design, and disclosure frameworks.

    By mapping national adaptation priorities across ASEAN Member States, the white paper identifies areas of convergence that can serve as a regional baseline for adaptation-aligned finance. It also proposes for discussion a set of key principles for the mARs Guide, which complement the existing Five Core Principles of the ASEAN Taxonomy and its Guiding Principles for EO2. The proposed principles for the mARs Guide underscore that the guide would be:

    • Science-based and evidence-led
    • Context-relevant and locally prioritized
    • Inclusive across AMS
    • Maladaptation risk management (uncertainty-aware)
    • Interoperable and comparable
    • Usable for finance and the real economy

    Together, these findings and principles establish the methodological foundation for the mARs Guide to become a key regional reference. They also highlight how it can complement the ASEAN Taxonomy and support the application of existing assessment requirements by providing more detailed information on adaptation-relevant technologies and activities, as well as additional guidance in conducting maladaptation and climate risk and vulnerability assessments.

    “This white paper is a critical step in building the foundations for adaptation finance in ASEAN. By aligning financial flows with resilience outcomes, the mARs Guide will help ensure that capital markets play their part in safeguarding communities and ecosystems against climate risks.”

    – Eric Usher, Head of UNEP FI

    A long-term, collaborative effort

    Financial institutions and market participants from across ASEAN have contributed valuable feedback throughout the process, helping to ensure that as the mARs Guide is developed, it will reflect both climate science and practical considerations. This multi-stakeholder exchange underscores the importance of dialogue between the public and private sectors in advancing a coherent, proportionate, and credible policy enabling environment for adaptation finance.

    “Our mitigation efforts need to be supported by adaptation action as climate change impacts intensify. Guided by the key principles set out in the white paper, the mARs Guide will be developed to help providers and users of finance identify the technologies and approaches that capital should support to achieve the paradigm shift needed for resilience.”

    – Eugene Wong, CEO of SFIA

    UNEP FI is supporting the ACMF’s work in partnership with SFIA and a broad community of technical experts and financial institutions, in close consultation with the ASEAN Taxonomy Board. The European Union’s Sustainable Finance Advisory Hub (EUSFAH) has provided technical and financial support to this project.

    The next phases of work—carrying through 2026 and 2027 with SEC Philippines and Monetary Authority of Singapore here as succeeding Chair of ACMF, respectively—will build on these principles to develop operational guidance and practical tools that under the mARs Guide. Stakeholders are encouraged to engage with the process and contribute to the development of the Guide. By working together, ASEAN can build a financial system that mobilizes more investments towards the decarbonization of the region, while enhancing its resilience and adaptive capacity.

     

     

     

    * About the partners involved in the collaboration

    ASEAN Capital Markets Forum (ACMF): The ACMF is a high-level grouping of capital market regulators from all 11 ASEAN jurisdictions, namely Brunei Darussalam, Cambodia, Indonesia, Lao PDR, Malaysia, Myanmar, Philippines, Singapore, Thailand, Timor-Leste and Vietnam. The ACMF’s primary goal is to develop a deep, liquid and integrated regional capital market.

    ASEAN Taxonomy Board (ATB): The ATB was set up in 2021 under the auspices of the ASEAN Finance Ministers and Central Bank Governors’ Meeting (AFMGM) and is jointly driven by the ACMF, ASEAN Insurance Regulators Meeting (AIRM), the Senior Level Committee on Financial Integration (SLC) and the Working Committee on Capital Market Development (WC-CMD). Its establishment is a response to the call at the 6th AFMGM to work towards “furthering a cohesive sustainable finance agenda cutting across banking, capital markets and insurance areas at the ASEAN Finance Ministers’ Meeting and AFMGM respectively, with greater coordination amongst the relevant ASEAN working committees.”

    Securities Commission Malaysia (SC): The SC was established on 1 March 1993 under the Securities Commission Act 1993 (SCA). It is a self-funded statutory body entrusted with the responsibility to regulate and develop the Malaysian capital market. Its mission is to promote and maintain fair, efficient, secure and transparent securities and derivatives markets; and facilitate the orderly development of an innovative and competitive capital market.

    Sustainable Finance Institute Asia (SFIA): SFIA is an independent institute established to catalyse ideas on sustainable finance at the policy level, as well as propel action in support of those policy ideas in Asia, particularly in ASEAN. It aims to provide thought leadership and act as a one stop centre for sustainable finance in ASEAN through collaborations with governments, regulators, central banks, multilateral development banks, industry, academia and non-governmental organisations.

    The EU Sustainable Finance Advisory Hub: The EU Sustainable Finance Advisory Hub is a technical assistance facility funded by the EU and BMZ. It supports low and middle income countries in developing credible and interoperable sustainable finance taxonomies tailored to their environmental, social, and economic contexts.

    UNEP Finance Initiative (UNEP FI): UNEP FI brings together a large network of banks, insurers, and investors that collectively catalyzes action across the financial system to deliver more sustainable global economies. Financial institutions work with UNEP FI on a voluntary basis, and UNEP FI helps them to apply the industry frameworks and develop practical guidance and tools to position their businesses for the transition to a sustainable and inclusive economy.

    Continue Reading

  • Alphabet’s stock rises as possible Meta chip deal highlights new twist in the AI trade

    Alphabet’s stock rises as possible Meta chip deal highlights new twist in the AI trade

    By Emily Bary

    Meta reportedly is considering using Alphabet’s custom chips for its data centers. Nvidia and AMD shares fall on the prospect of more formidable semiconductor competition.

    Google designs in-house chips in partnership with Broadcom.

    Meta Platforms investors may not know how to feel about the Facebook parent company’s stepped-up artificial-intelligence investments lately, but Alphabet investors seem to be liking the sound of them.

    Shares of Alphabet (GOOG) (GOOGL) rose 2.7% in after-hours trading Monday, toward fresh highs, after The Information reported that Meta (META) was considering outfitting its data centers with perhaps billions of dollars’ worth of custom chips from Google.

    The prospect of this development positions Alphabet as a more foreboding rival to Nvidia (NVDA) and Advanced Micro Devices (AMD) in the red-hot market for AI infrastructure.

    Representatives from Meta and Google didn’t immediately respond to a MarketWatch request for comment.

    For Google, the report is the latest signal of broad-based AI momentum. The company said it trained its new Gemini 3 model on tensor processing units, its custom chips, and there seems to be growing outside interest in Google’s semiconductor work.

    See more: Google may be Nvidia’s biggest rival in chips – and now it’s upping its game

    Alphabet shares have surged 68% so far in 2025, with most of that coming in the past few months, reflecting optimism about Google’s TPU business as well as its Gemini AI model. The latest version has won praise in the technology world, reinforcing a view that Google is positioned to be an AI winner, perhaps at the expense of OpenAI.

    Shares of Alphabet’s suppliers continued to rise in conjunction with Google’s momentum. Broadcom shares (AVGO) advanced 1.7% in Monday’s extended trading, as the company partners with Alphabet on the TPUs. Celestica (CLS) and Lumentum Holdings (LITE), two optical suppliers whose stocks saw outsize increases in Monday’s regular session, added to their gains in the aftermarket.

    Don’t miss: Broadcom and these AI stocks are surging as plays on Alphabet’s rapid rise

    Meta shares ended fractionally higher in Monday’s extended session. The company’s talk of heightened AI spending spooked Wall Street in the wake of the company’s last earnings report in late October, with investors still unsure about whether the company will be able to monetize all its AI investments. Meta said that AI has helped it improve advertising products and recommendation engines, but the company has struggled to match rivals in terms of momentum for its AI chatbot.

    Meanwhile, an emerging narrative in the AI trade is that what’s good for Google and its universe of suppliers isn’t necessarily good for AI players generally. Google’s TPUs are a type of application-specific integrated circuit, and the debate over ASICs versus graphics processing units, like those made by Nvidia and AMD, is nothing new. But Google’s apparent internal and external momentum for its TPUs suggests budding competition for Nvidia, by far the most dominant seller of AI hardware to a broad list of customers, and AMD, which already has a relationship with Meta and has been trying to win more GPU business.

    See more: Google is crushing it. Why that’s worrying investors in Nvidia and other AI stocks.

    Shares of Nvidia and AMD each lost more than 1% in Monday’s after-hours trading.

    -Emily Bary

    This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

    (END) Dow Jones Newswires

    11-24-25 2223ET

    Copyright (c) 2025 Dow Jones & Company, Inc.

    Continue Reading

  • Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Biol Sci Med Sci. 2001;56(3):M146–56.

    Google Scholar 

  • Ensrud KE, Ewing SK, Taylor BC, Fink HA, Cawthon PM, Stone KL, et al. Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med. 2008;168(4):382–9.

    Google Scholar 

  • Satake S, Senda K, Hong YJ, Miura H, Endo H, Sakurai T, et al. Validity of the kihon checklist for assessing frailty status. Geriatr Gerontol Int. 2016;16(6):709–15.

    Google Scholar 

  • Clegg A, Hassan-Smith Z. Frailty and the endocrine system. Lancet Diabetes Endocrinol. 2018;6(9):743–52.

    Google Scholar 

  • Bianco AC, Kim BW. Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest. 2006;116(10):2571.

    Google Scholar 

  • Pappa T, Ferrara AM, Refetoff S. Inherited defects of thyroxine-binding protein. Best Pract Res Clin Endocrinol Metab. 2015;29(5):735–47.

    Google Scholar 

  • Nappi A, Moriello C, Morgante M, Fusco F, Crocetto F, Miro C. Effects of thyroid hormones in skeletal muscle protein turnover. J Basic Clin Physiol Pharmacol. 2024;35(4–5):253–64.

    Google Scholar 

  • Virgini VS, Rodondi N, Cawthon PM, Harrison SL, Hoffman AR, Orwoll ES, et al. Subclinical thyroid dysfunction and frailty among older men. J Clin Endocrinol Metab. 2015;100(12):4524–32.

    Google Scholar 

  • Bhalla NS, Vinales KL, Li M, Bhattarai R, Fawcett J, Harman SM. Low TSH is associated with frailty in an older veteran population independent of other thyroid function tests. Gerontol Geriatr Med. 2021;7:2333721420986028.

    Google Scholar 

  • Bertoli A, Valentini A, Cianfarani MA, Gasbarra E, Tarantino U, Federici M. Low FT3: a possible marker of frailty in the elderly. Clin Interv Aging. 2017;12:335–41.

    Google Scholar 

  • Okoye C, Arosio B, Carino S, Putrino L, Franchi R, Rogani S, et al. The free triiodothyronine/free thyroxine ratio is associated with frailty in older adults: a longitudinal multisetting study. Thyroid. 2023;33(2):169–76.

    Google Scholar 

  • Arosio B, Monti D, Mari D, Passarino G, Ostan R, Ferri E, et al. Thyroid hormones and frailty in persons experiencing extreme longevity. Exp Gerontol. 2020;138:111000.

    Google Scholar 

  • Pasqualetti G, Calsolaro V, Bernardini S, Linsalata G, Bigazzi R, Caraccio N, et al. Degree of peripheral thyroxin deiodination, frailty, and long-term survival in hospitalized older patients. J Clin Endocrinol Metab. 2018;103(5):1867–76.

    Google Scholar 

  • Yu ZW, Pu SD, Sun XT, Wang XC, Gao XY, Shan ZY. Impaired sensitivity to thyroid hormones is associated with mild cognitive impairment in euthyroid patients with type 2 diabetes. Clin Interv Aging. 2023;18:1263–74.

    Google Scholar 

  • Tamura Y, Ishikawa J, Fujiwara Y, Tanaka M, Kanazawa N, Chiba Y, et al. Prevalence of frailty, cognitive impairment, and sarcopenia in outpatients with cardiometabolic disease in a frailty clinic. BMC Geriatr. 2018;18(1):264.

    Google Scholar 

  • Oba K, Ishikawa J, Tamura Y, Fujita Y, Ito M, Iizuka A, et al. Serum growth differentiation factor 15 levels predict the incidence of frailty among patients with cardiometabolic diseases. Gerontology. 2024;70(5):517–25.

    Google Scholar 

  • Tamura Y, Shimoji K, Ishikawa J, Murao Y, Yorikawa F, Kodera R, et al. Association between white matter alterations on diffusion tensor imaging and incidence of frailty in older adults with cardiometabolic diseases. Front Aging Neurosci. 2022;14:912972.

    Google Scholar 

  • Furuto-Kato S, Araki A, Chiba Y, Nakamura M, Shintani M, Kuwahara T, et al. Relationship between the thyroid function and cognitive impairment in the elderly in Japan. Intern Med. 2022;61(20):3029–36.

    Google Scholar 

  • Laclaustra M, Moreno-Franco B, Lou-Bonafonte JM, Mateo-Gallego R, Casasnovas JA, Guallar-Castillon P, et al. Impaired sensitivity to thyroid hormones is associated with diabetes and metabolic syndrome. Diabetes Care. 2019;42(2):303–10.

    Google Scholar 

  • Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.

    Google Scholar 

  • Dentice M, Marsili A, Ambrosio R, Guardiola O, Sibilio A, Paik JH. The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration. J Clin Invest. 2010;120(11):4021–30.

    Google Scholar 

  • Chopra IJ, Chopra U, Smith SR, Reza M, Solomon DH. Reciprocal changes in serum concentrations of 3,3’,5-triiodothyronine (T3) in systemic illnesses. J Clin Endocrinol Metab. 1975;41(06):1043–9.

    Google Scholar 

  • Ostan R, Monti D, Mari D, Arosio B, Gentilini D, Ferri E, et al. Heterogeneity of thyroid function and impact of peripheral thyroxine deiodination in centenarians and semi-supercentenarians: association with functional status and mortality. J Gerontol A Biol Sci Med Sci. 2019;74(6):802–10.

    Google Scholar 

  • Alonso SP, Valdés S, Maldonado-Araque C, Lago A, Ocon P, Calle A, et al. Thyroid hormone resistance index and mortality in euthyroid subjects: Di@bet.es study. Eur J Endocrinol. 2021;186(1):95–103.

    Google Scholar 

  • Barzilay JI, Blaum C, Moore T, Xue QL, Hirsch CH, Walston JD, et al. Insulin resistance and inflammation as precursors of frailty: the cardiovascular health study. Arch Intern Med. 2007;167(7):635–41.

    Google Scholar 

  • Carvalhaes-Neto N, Huayllas MK, Ramos LR, Cendoroglo MS, Kater CE, Cortisol. DHEAS and aging: resistance to cortisol suppression in frail institutionalized elderly. J Endocrinol Invest. 2003;26(1):17–22.

    Google Scholar 

  • Lv F, Cai X, Li Y, Zhang X, Zhou X, Han X, et al. Sensitivity to thyroid hormone and risk of components of metabolic syndrome in a Chinese euthyroid population. J Diabetes. 2023;15(10):900–10.

    Google Scholar 

  • Liu C, Hua L, Liu K, Xin Z. Impaired sensitivity to thyroid hormone correlates to osteoporosis and fractures in euthyroid individuals. J Endocrinol Invest. 2023;46(10):2017–29.

    Google Scholar 

  • Chen S, Sun X, Zhou G, Jin J, Li Z. Association between sensitivity to thyroid hormone indices and the risk of osteoarthritis: an NHANES study. Eur J Med Res. 2022;27(1):114.

    Google Scholar 

  • Wronski ML, Tam FI, Seidel M, Mirtschink P, Poitz DM, Bahnsen K, et al. Associations between pituitary-thyroid hormones and depressive symptoms in individuals with anorexia nervosa before and after weight-recovery. Psychoneuroendocrinology. 2022;137:105630.

    Google Scholar 

  • De Vito P, Incerpi S, Pedersen JZ, Luly P, Davis FB, Davis PJ. Thyroid hormones as modulators of immune activities at the cellular level. Thyroid. 2011;21(8):879–90.

    Google Scholar 

  • Wachowska K, Gałecki P. Inflammation and cognition in depression: a narrative review. J Clin Med. 2021;10(24):5859.

    Google Scholar 

  • Ma YC, Ju YM, Cao MY, Yang D, Zhang KX, Liang H, et al. Exploring the relationship between malnutrition and the systemic immune-inflammation index in older inpatients: a study based on comprehensive geriatric assessment. BMC Geriatr. 2024;24(1):19.

    Google Scholar 

  • Jiang L, Zhou L, Liu J, Wang Y, Wang G. Sex differences in the association between thyroid hormone sensitivity and cardiovascular-kidney-metabolic syndrome. J Clin Endocrinol Metab. 2025;4:dgaf059.

    Google Scholar 

  • Wang Q, Tao A, Zhang Y, Li X, Lin Q, Liu F, et al. Psychometric properties of the simplified Chinese version of Kihon checklist in the Chinese older people. Int J Older People Nurs. 2023;18(2):e12524.

    Google Scholar 

  • Assantachai P, Muangpaisan W, Intalapaporn S, Jongsawadipatana A, Arai H. Kihon checklist: Thai version. Geriatr Gerontol Int. 2021;21(8):749–52.

    Google Scholar 

Continue Reading

  • Baker McKenzie Advises Current Shareholders (Including Funds Advised by ARCHIMED as Controlling Shareholder) on the Sale of Citieffe Group to PolyMed | Newsroom

    Baker McKenzie Advises Current Shareholders (Including Funds Advised by ARCHIMED as Controlling Shareholder) on the Sale of Citieffe Group to PolyMed | Newsroom

    Baker McKenzie advised the current shareholders on the sale of all their equity interests in Medistream SA, a Swiss corporation holding all equity interests in Citieffe SRL, an Italian medical devices manufacturer, and its subsidiaries in the United States and Mexico (“Citieffe Group”), to Poly Medicure B.V., Amsterdam, Netherlands, a wholly owned subsidiary of Poly Medicure Limited, an Indian public company (“PolyMed”). Funds advised by ARCHIMED, a global private equity firm focused on the healthcare sector, were the majority shareholders in Citieffe Group.

    The Citieffe Group is an Italy-based manufacturer specializing in the orthopedic trauma and extremities segment, with a direct presence in Italy, the United States and Mexico, as well as distribution across 25 countries. The transaction was completed on 6 November 2025.

    This strategic acquisition provides PolyMed with a gateway into the global orthopedics market, particularly in the trauma and extremities segment — the fastest growing and most resilient category within orthopedics. As part of PolyMed, the Citieffe Group is expected to benefit from enhanced R&D and manufacturing capabilities, including potential cost efficiencies through operations in India.

    Baker McKenzie advised the shareholders of Citieffe Group, including ARCHIMED, on all legal and tax aspects of the transaction.

    M&A Partners Alexander Fischer and Olha Deminaniuk led the team, which included Alexander Blaeser (partner, M&A), Susanne Liebel-Kotz (partner, tax), Vinzenz Sutter (associate, M&A), Kiara Sharifi (associate, M&A), Kasper Projer (associate, Dispute Resolution/International Commercial & Trade) and Anna Zellweger (associate, International Commercial & Trade).

    Continue Reading

  • Focused ultrasound combined with chemotherapy improves survival in glioblastoma patients

    Focused ultrasound combined with chemotherapy improves survival in glioblastoma patients

    Patients with the deadliest form of brain cancer, glioblastoma, who received MRI-guided focused ultrasound with standard-of-care chemotherapy had a nearly 40 percent increase in overall survival in a landmark trial of 34 patients led by University of Maryland School of Medicine (UMSOM) researchers. This is the first time researchers have demonstrated a potential survival benefit from using focused ultrasound to open the blood-brain barrier to improve delivery of chemotherapy to the tumor site in brain cancer patients after surgery.

    Our results are very encouraging. Using focused ultrasound to open the blood-brain barrier and deliver chemotherapy could significantly increase patient survival, which other ongoing studies are seeking to confirm and expand.”

    Graeme Woodworth, MD, study principal investigator, Professor and Chair of Neurosurgery at UMSOM and Neurosurgeon-In-Chief at the University of Maryland Medical Center (UMMC)

    The findings of this groundbreaking safety, feasibility, and comparative trial involved glioblastoma patients who were given focused ultrasound to open their blood-brain barrier before getting chemotherapy; they were matched to a rigorously selected control group of 185 glioblastoma patients with similar characteristics who received the standard dose of the chemotherapy drug, temozolomide, without receiving focused ultrasound. Trial participants were initially treated with surgery to remove their brain tumor, followed by six weeks of chemotherapy and radiation, and up to six monthly focused-ultrasound treatments plus temozolomide.

    Results were published in the journal Lancet Oncology and show that trial participants had nearly 14 months of median progression-free survival, compared to eight months in the control group. In terms of overall survival, trial participants, on average, lived for more than 30 months compared to 19 months in the control group.

    The study builds on more than a decade of intensive research to test the safety and feasibility of opening the blood-brain barrier using focused ultrasound first in animal studies and then in patients. It was led by Dr. Woodworth and was conducted at UMMC and four other clinical sites affiliated with the University of Toronto, Harvard University, University of Virginia, and West Virginia University. “We also demonstrated that this could be a useful technique that enables us to better monitor patients to determine if their brain cancer has progressed,” said Dr. Woodworth, who also serves as Director of the Brain Tumor Program at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC).

    He and his team demonstrated that opening the blood-brain barrier facilitated the use of a
    “liquid biopsy,” which is a blood test that detects cancer biomarkers, which can include DNA fragments, proteins and other components from the liquid environment surrounding the tumor site.

    Such biomarkers have been used in other cancers to determine whether the tumor has remained stable or has the potential to progress or even metastasize. Up until now, however, these tests have not been utilized in brain cancer patients since most components can never pass into the bloodstream from the brain due to the blood-brain barrier.
    “These liquid biomarkers were found to be closely concordant with the patient outcomes over time, progression-free survival and overall survival,” said Dr. Woodworth.

    While temozolomide is the standard treatment for glioblastoma, the drug typically gets blocked by the blood-brain barrier with studies showing that less than 20 percent reaches the brain in patients. This study did not determine the exact amount of temozolomide to reach the brain in each patient, but earlier studies have shown that opening the blood-brain barrier before delivering chemotherapy can dramatically increase the amount that gets to the original tumor site.

    Glioblastoma is the most common and deadliest type of malignant brain tumor. The five-year survival rate is only 5.5 percent, and patients live an average of 14 to 16 months after diagnosis when treated with surgery, radiation, and chemotherapy when appropriate. The malignancy nearly always recurs even after it is removed due to residual infiltrating cancer cells that remain after treatment.

    The blood-brain barrier is a specialized network of vascular and brain cells that acts as the brain’s security system to protect against invasion by dangerous toxins and microbes. It can be opened temporarily using a specialized focused ultrasound device. This process starts with injecting microscopic inert gas-filled bubbles into the patient’s bloodstream. Guided by an MRI, precise brain regions are targeted while the injected microbubbles are circulating.

    “Upon excitation under low-intensity ultrasound waves, the microbubbles oscillate within the energy field, causing temporary mechanical perturbations in the walls of the brain blood vessels,” said Pavlos Anastasiadis, PhD, an Assistant Professor of Neurosurgery at UMSOM who is an expert in ultrasound biophysics.

    Prior studies led by Dr. Woodworth and this trial’s co-investigators showed that opening the blood-brain barrier temporarily can be safely and feasibly performed in brain tumor patients. He and his team conducted this procedure in the first brain cancer patient in the U.S. in 2018 at UMMC after the US Food and Drug Administration (FDA) approved the inaugural clinical trial.

    “Dr. Woodworth’s findings are deeply exciting and a significant step forward for the field,” said Taofeek K. Owonikoko, MD, PhD, UMGCCC Executive Director. “Patients with glioblastoma have had few effective treatment options, and UMGCCC is proud to be at the forefront of efforts to bring hope to these patients and their families.”

    Future trials could use focused ultrasound alongside other chemotherapy agents to test the effectiveness of drugs never used in brain cancer due to their ineffectiveness at crossing the blood-brain barrier.

    “This groundbreaking trial has provided a potential new prognostic and therapeutic paradigm for the 15,000 Americans who are diagnosed every year with this deadly form of brain cancer,” said UMSOM Dean Mark T. Gladwin, MD, who is the John Z. and Akiko K. Bowers Distinguished Professor and Vice President for Medical Affairs at University of Maryland, Baltimore. “The release of biomarkers into the bloodstream offers a possible new method for simple and routine monitoring of brain regions without the need for invasive biopsies. Having the ability to open the blood-brain barrier could also usher in the testing of new therapeutics to see whether they offer further life-extending benefits.”

    “For the thousands of people who receive this devastating diagnosis each year, the significance of this advancement cannot be overstated,” said Bert W. O’Malley, MD, President and CEO of UMMC. “The success of this trial brings new momentum and further accelerates investigation of targeted therapies for glioblastoma and other brain cancers. Hope has been redefined for these families.”

    Dr. Woodworth is also the co-leader of a larger diagnostics-focused pivotal focused ultrasound trial in glioblastoma patients called LIBERATE (NCT05383872) in partnership with ReFOCUSED (The Research Consortium for Transcranial Focused UltraSound-Enhanced Drug Delivery & Diagnostics.) ReFOCUSED is a growing group of researchers from over 20 sites across North America whose goal is to use the new opportunities offered by MRI-guided focused ultrasound to improve the clinical outcomes of brain diseases. The LIBERATE trial is currently closed to enrollment.

    This trial was funded by the device manufacturer Insightec Inc. (Miami, FL), an MRI-guided focused ultrasound device company, and the National Institutes of Health (NIH) (R21NS113016).

    Source:

    University of Maryland School of Medicine

    Journal references:

    Woodworth, G. F., et al. (2025) Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial. The Lancet Oncology. DOI: 10.1016/S1470-2045(25)00492-9. https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00492-9/fulltext

    Continue Reading

  • Resurgence of malaria in the Amhara Region, Ethiopia (2014–2024): trends, spatial expansion, and control challenges | Malaria Journal

    Resurgence of malaria in the Amhara Region, Ethiopia (2014–2024): trends, spatial expansion, and control challenges | Malaria Journal

  • WHO. World malaria report 2024: addressing inequity in the global malaria response. Geneva: World Health Organization; 2024.

    Google Scholar 

  • U.S. President’s Malaria Initiative (PMI). Ethiopia: malaria operational plan FY 2024. Washington DC: United States Agency for International Development (USAID); 2024.

    Google Scholar 

  • WHO. Disease outbreak news: malaria in Ethiopia 2024 update. Geneva: World Health Organization; 2024.

    Google Scholar 

  • Federal Ministry of Health of Ethiopia. Malaria elimination strategic plan 2021–2025. Addis Ababa: Federal Ministry of Health of Ethiopia; 2020.

    Google Scholar 

  • Taffese HS, Hemming-Schroeder E, Koepfli C, Tesfaye G, Lee MC, Kazura J, et al. Malaria epidemiology and interventions in Ethiopia from 2001 to 2016. Infect Dis Poverty. 2018;7:103.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Alemu K, Worku A, Berhane Y, Kumie A. Spatiotemporal clusters of malaria cases at village level, northwest Ethiopia. Malar J. 2014;13:223.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Ministry of Health. National malaria elimination programme. Addia Ababa: Ministry of Health; 2021.

    Google Scholar 

  • Zhou G, Taffese HS, Zhong D, Wang X, Lee MC, Degefa T, et al. Resurgence of clinical malaria in Ethiopia and its link to Anopheles stephensi invasion. Pathogens. 2024;13:748.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Emiru T, Getachew D, Murphy M, Sedda L, Ejigu LA, Bulto MG, et al. Evidence for a role of Anopheles stephensi in the spread of drug- and diagnosis-resistant malaria in Africa. Nat Med. 2023;29:3203–11.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Balkew M, Mumba P, Dengela D, Yohannes G, Getachew D, Yared S, et al. Geographical distribution of Anopheles stephensi in eastern Ethiopia. Parasit Vectors. 2020;13:35.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Merga H, Degefa T, Birhanu Z, Abiy E, Lee MC, Yan G, et al. Urban malaria and its determinants in eastern Ethiopia: the role of Anopheles stephensi and urbanization. Malar J. 2024;23:303.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Sedda L, QiQ TAJ. A geostatistical analysis of the association between armed conflicts and Plasmodium falciparum malaria in Africa. Malar J. 2015;14:500.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Teka H, Golassa L, Medhin G, Balkew M, Sisay C, Gadisa E, et al. Trend analysis of malaria in urban settings in Ethiopia from 2014 to 2019. Malar J. 2023;22:235.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Tadesse FG, Ashine T, Teka H, Esayas E, Messenger LA, Chali W, et al. Anopheles stephensi mosquitoes as vectors of Plasmodium vivax and falciparum, Horn of Africa, 2019. Emerg Infect Dis. 2021;27:603–7.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Brhane BG, Fola AA, Nigussie H, Leonetti A, Kassa M, Hailgiorgis H, et al. Rising prevalence of Plasmodium falciparum artemisinin partial resistance mutations in Ethiopia. Commun Med. 2025;5:297.

    PubMed 
    PubMed Central 

    Google Scholar 

  • World Health Organization. World malaria report. Geneva: World Health Organization; 2022.

    Google Scholar 

  • Hay SI, Cox J, Rogers DJ, Randolph SE, Stern DI, Shanks GD, et al. Regional warming and malaria resurgence. Nature. 2002;420:627–8.

    Google Scholar 

  • Zhou G, Minakawa N, Githeko AK, Yan G. Climate variability and malaria epidemics in the highlands of East Africa. Trends Parasitol. 2005;21:54–6.

    PubMed 

    Google Scholar 

  • Cohen JM, Smith DL, Cotter C, Ward A, Yamey G, Sabot OJ, et al. Malaria resurgence: a systematic review and assessment of its causes. Malar J. 2012;11:122.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Raouf S, Mpimbaza A, Kigozi R, Sserwanga A, Rubahika D, Katamba H, et al. Resurgence of malaria following discontinuation of indoor residual spraying of insecticide in an area of Uganda with previously high-transmission intensity. Clin Infect Dis. 2017;65:453–60.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Sherrard-Smith E, Hogan AB, Hamlet A, Watson OJ, Whittaker C, Winskill P, et al. The potential public health consequences of COVID-19 on malaria in Africa. Nat Med. 2020;26:1411–6.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Rogerson SJ, Beeson JG, Laman M, Poespoprodjo JR, William T, Simpson JA, et al. Identifying and combating the impacts of COVID-19 on malaria. BMC Med. 2020;18:239.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Minwuyelet A, Eshetu T, Milikit D, Aschale Y. Prevalence and risk factors of asymptomatic Plasmodium infection in Gondar Zuria District, Northwest Ethiopia. Infect Drug Resist. 2020;13:3969–75.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Solomon A, Kahase D, Alemayehu M. Trend of malaria prevalence in Wolkite health center: an implication towards the elimination of malaria in Ethiopia by 2030. Malar J. 2020;19:112.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Minwuyelet A, Abiye M, Zeleke AJ, Getie S. Plasmodium gametocyte carriage in humans and sporozoite rate in anopheline mosquitoes in Gondar Zuria District, Northwest Ethiopia. PLoS ONE. 2024;19:e0306289.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Yalew AW. Achievements, gaps, and emerging challenges in controlling malaria in Ethiopia. Front Trop Dis. 2022;2:771030.

    Google Scholar 

  • Dembélé L, Franetich J-F, Lorthiois A, Gego A, Zeeman A-M, Kocken CH, et al. Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures. Nat Med. 2014;20:307–12.

    PubMed 

    Google Scholar 

  • Minwuyelet A, Yewhalaw D, Atenafu G. Retrospective analysis of malaria prevalence over ten years (2015–2024) at Bichena Primary Hospital, Amhara region, Ethiopia. PLoS ONE. 2025;20:e0322570.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Moltot T, Bekele G, Gebreegziabher ZA, Lemma T, Sisay M, Silesh M, et al. A five-year malaria surveillance data analysis of North Shewa zone, Amhara region, Ethiopia: July 2018 to June 2023. Malar J. 2024;23:187.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Abere A, Ayalew S, Wondale B, Tigabu F, Gizachew N, Tesfaye T, et al. Dynamic shift of malaria cases in northwest Ethiopia: a 10-year retrospective cohort data analysis from 2012 to 2021. Front Malar. 2025;3:1460491.

    Google Scholar 

  • Nigussie TZ, Zewotir TT, Muluneh EK. Seasonal and spatial variations of malaria transmissions in northwest Ethiopia: evaluating climate and environmental effects using generalized additive model. Heliyon. 2023;9:e15252.

    PubMed 
    PubMed Central 

    Google Scholar 

  • World Health Organization. Malaria surveillance, monitoring & evaluation: a reference manual. Geneva: World Health Organization; 2018.

    Google Scholar 

  • Central Statistical Agency (CSA) of Ethiopia. Population projection of Ethiopia for all regions at Wereda level from 2014–2017. Addis Ababa: CSA; 2013.

    Google Scholar 

  • NASA Shuttle Radar Topography Mission Global 1 arc second number. NASA Land Processes Distributed Active Archive Center. 2013.

  • Central Statistical Agency of Ethiopia. Population and housing census 2023/2024: Amhara Region. Addis Ababa: CSA; 2024.

    Google Scholar 

  • Rothman KJ, Greenland S, Lash TL. Modern epidemiology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008.

    Google Scholar 

  • Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–51.

    PubMed 

    Google Scholar 

  • Duyar İ. A Bayesian approach in model selection. Ankara Univ J Fac Educ Sci (JFES). 1995;28(1):95–106.

    Google Scholar 

  • WHO. World malaria report 2017. Geneva: World Health Organization; 2017.

    Google Scholar 

  • USAID President’s Malaria Initiative. Ethiopia malaria operational plan FY 2023. Washington, DC: USAID; 2023.

    Google Scholar 

  • EPHI. Ethiopia national malaria indicator survey 2015. Addis Ababa: Ethiopian Public Health Institute; 2016.

    Google Scholar 

  • Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526:207–11.

    PubMed 
    PubMed Central 

    Google Scholar 

  • World Health Organization. World malaria report. Geneva: World Health Organization; 2023.

    Google Scholar 

  • WHO. World malaria report. Geneva: World Health Organization; 2021.

    Google Scholar 

  • Price RN, Commons RJ, Battle KE, Thriemer K, Mendis K. Plasmodium vivax in the era of the shrinking P. falciparum map. Trends Parasitol. 2020;36:560–70.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Howes RE, Battle KE, Mendis KN, Smith DL, Cibulskis RE, Baird JK, et al. Global epidemiology of Plasmodium vivax. Am J Trop Med Hyg. 2016;95(6 Suppl):15–34.

    PubMed 
    PubMed Central 

    Google Scholar 

  • White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011;10:297.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Yenew C, Mulatu S, Alamneh A. The trend of malaria cases, positivity rate, and determinant factors in the Amhara Regional State, Ethiopia: a mixed method. Case Rep Infect Dis. 2021;2021:2131720.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Ahmed A, Khogali R, Elnour M-AB, Nakao R, Salim B. Emergence of the invasive malaria vector Anopheles stephensi in Khartoum State, Central Sudan. Parasit Vectors. 2021;14:511.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Haileselassie W, Parker DM, Taye B, David RE, Zemene E, Lee MC, et al. Burden of malaria, impact of interventions, and climate variability in western Ethiopia: an area with large irrigation-based farming. BMC Public Health. 2022;22:196.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Gething PW, Smith DL, Patil AP, Tatem AJ, Snow RW, Hay SI. Climate change and the global malaria recession. Nature. 2010;465:342–5.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Jalilian A, Ayana GM, Ashine T, Hailemeskel E, Ebstie YA, Molla E, et al. Waning success: a 2013–2022 spatial and temporal trend analysis of malaria in Ethiopia. Infect Dis Poverty. 2024;13:93.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Bousema T, Griffin JT, Sauerwein RW, Smith DL, Churcher TS, Takken W, et al. Hitting hotspots: spatial targeting of malaria for control and elimination. PLoS Med. 2012;9:e1001165.

    PubMed 
    PubMed Central 

    Google Scholar 

  • World Health Organization. Consolidated guidelines for malaria. Geneva: World Health Organization; 2021.

    Google Scholar 

  • Shretta R, Avancena AL, Hatefi A. The economics of malaria control and elimination: a systematic review. Malar J. 2016;15:593.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Okell LC, Ghani AC, Lyons E, Drakeley CJ. Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis. J Infect Dis. 2009;200:1509–17.

    PubMed 

    Google Scholar 

  • Cox J, Craig M, Le Sueur D, Sharp B. Mapping malaria risk in the highlands of Africa. Durban: MARA/HIMAL Technical Report; 1999.

    Google Scholar 

  • Lindsay SW, Martens WJ. Malaria in the African highlands: past, present and future. Bull World Health Organ. 1998;76:33–45.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Continue Reading

  • Opening Remarks by AMRO Director/CEO Yasuto Watanabe at the 4th ASEAN+3 Economic Cooperation & Financial Stability Forum (AMRO Forum) – ASEAN+3 Macroeconomic Research Office

    Opening Remarks by AMRO Director/CEO Yasuto Watanabe at the 4th ASEAN+3 Economic Cooperation & Financial Stability Forum (AMRO Forum) – ASEAN+3 Macroeconomic Research Office

    Distinguished guests, ladies and gentlemen,

    It is a privilege to welcome you to the 4th AMRO Forum, co-organized with the Hong Kong Monetary Authority and the Bank for International Settlements. My deep appreciation goes to Eddie Yue and Zhang Tao for their partnership, to our distinguished speakers and panelists, and to all of you—joining us both in person and online—for being here today.

    From Fragmentation to Resilience—this theme speaks directly to the realities facing the ASEAN+3 region and the global economy.

    The world is undergoing structural change. Supply chains are being rewired, trade is increasingly shaped by strategic considerations, and technology has become contested terrain. The monetary and financial system is evolving—from growing interest in currency diversification to the emergence of parallel payment architectures and shifting capital flow patterns.

    Yet the world remains deeply interconnected. Capital continues to move across borders. Policy decisions in major economies reverberate through our markets instantly. Financial institutions remain globally active, and our markets still react to the same global risk signals.

    We are navigating a world in transition—no longer defined by the old rules of globalization, but not yet anchored in a new and stable order. Amid global fragmentation, the architecture of interconnection needs to evolve.

    The implications are especially profound for ASEAN+3. Our region sits at the heart of global economic realignment and contributes more than 40% of global GDP growth. What happens in the world economy matters to us—and what we do as a region increasingly shapes global outcomes.

    The choices ASEAN+3 makes now on integration, cooperation, and the future architecture of our financial system will influence not only our own trajectory but the stability and resilience of the global system.

    Today’s discussions will confront these issues with candor and ambition.

    This morning, we focus on navigating macroeconomic risks in a fragmented world. Fragmentation will continue—but deeper integration remains one of our strongest anchors. Strengthening buffers and aligning policies will reinforce the region’s collective resilience.

    In the afternoon, we turn to finance. Markets are evolving rapidly, driven by non-bank intermediation and powerful waves of digital innovation. Just two weeks ago at the Singapore FinTech Festival, I witnessed firsthand how global innovators—from major financial institutions to cutting-edge start-ups—are reimaging payments, tokenization, and the very architecture of financial services. The message was unmistakable: technology is rewriting the nature of finance. These developments bring enormous opportunities for ASEAN+3 but they also open new channels for shocks. Our task is clear: harness innovation with confidence, while reinforcing the frameworks that keep our financial systems stable.

    Across both sessions, one message will guide our discussion: resilience in ASEAN+3 is not achieved through isolation. It is built through adaptability, diversification, and the capacity to absorb shocks without losing cohesion.

    To achieve this, ASEAN+3 must continue to move with purpose—deepen financial cooperation, accelerate investment in digital and payment infrastructure, and strengthen the institutions that enable collective action.

    AMRO is fully committed to this cause. We will continue to enhance our surveillance, expand our technical assistance, and reinforce the region’s financial safety net in support of the region’s evolving needs.

    The challenges are complex, but the expertise gathered here today—both on-site and online—is exceptional. I am confident that our discussions will yield concrete insights for the next phase of regional cooperation.

    Let us use this Forum to think boldly—and to speak with the voice of a region that is shaping its own future.

    Thank you.


    Continue Reading

  • 4th AMRO Forum: Deepen ASEAN+3 Integration for Resilience Amid Fragmentation – ASEAN+3 Macroeconomic Research Office

    4th AMRO Forum: Deepen ASEAN+3 Integration for Resilience Amid Fragmentation – ASEAN+3 Macroeconomic Research Office

    HONG KONG, China, November 25, 2025 – The ASEAN+3 Macroeconomic Research Office (AMRO) this morning opened the 4th ASEAN+3 Economic Cooperation and Financial Stability Forum (AMRO Forum) in Hong Kong, China, co-organized this year with the Hong Kong Monetary Authority (HKMA) and the Bank for International Settlements (BIS).

    Set against a global environment marked by shifting alignments and growing fragmentation, this Forum has gathered senior policymakers, economic experts, and thought leaders across the ASEAN+3 region and beyond to deliberate on how to safeguard financial stability, strengthen macro-financial resilience, and drive sustainable long-term prosperity. Under the theme Fragmentation to Resilience: Macro-financial Stability and Regional Integration in ASEAN+3, the event has called for deeper regional cooperation to navigate rising fragmentation and uncertainty.

    AMRO Director/CEO Yasuto Watanabe opened the Forum alongside HKMA Chief Executive Eddie Yue and BIS Chief Representative for Asia and the Pacific Tao Zhang.

    Mr. Watanabe said: “Amid global fragmentation, the architecture of interconnection needs to evolve. To anchor resilience, ASEAN+3 region must act together to strengthen integration, reinforce our financial frameworks, and ensure that the region remains adaptable, diversified, and capable of absorbing shocks.”

    Mr. Yue of the HKMA said: “Through enhanced regional collaboration and integration, ASEAN+3 economies have strengthened their resilience to shocks amid a challenging external environment. I am confident that the discussions today—on macroeconomic risks, on the shifting global financial landscape, and on the priorities for cooperation—will yield valuable insights that will guide our collective efforts in the years to come.”

    With a focus on issues facing Asian central banks, Mr. Zhang of the BIS highlighted that “close cooperation among central banks and between the public and private sectors, both within the region and beyond, is essential to withstand economic risks. Today’s forum provides a valuable opportunity for all of us to exchange insights, deepen common understanding, and collectively reflect on the region’s policy priorities,” he said.

    The Forum program features two major sessions:

    Session 1: Macroeconomic Risks and Regional Integration Amid Global Fragmentation

    Keynote speakers are Heiwai Tang (Director, Asia Global Institute, The University of Hong Kong) and Barry Eichengreen (Distinguished Professor, University of California, Berkeley). They will lead into a panel moderated by Dong He (Chief Economist, AMRO) and featuring:

    • Marzunisham Omar (Deputy Governor, Bank Negara Malaysia)
    • Haibin Zhu (Executive Director (Research), HKMA)
    • Chantavarn Sucharitakul (Chair, AMRO Advisory Panel)
    • Johanna Chua (Managing Director, Head of Emerging Market Economics & Chief Asia Economist, Citigroup)

    Session 2: The Changing Global Financial Landscape: Implications for Monetary and Financial Stability

    Keynotes will be delivered by Julia Leung (Chief Executive Officer, Securities and Futures Commission) and Hyun Song Shin (Economic Adviser & Head of Monetary & Economic Department, BIS). This will be followed by a panel moderated by Daniel Rees (Head of Central Bank Cooperation, Monetary & Economic Department, BIS) and featuring:

    • Zeno Ronald R. Abenoja (Deputy Governor, Bangko Sentral ng Pilipinas)
    • Min Soo Kwon (Deputy Governor, Bank of Korea)
    • Alicia Garcia-Herrero (Chief Economist for Asia-Pacific, Natixis)
    • Arup Ghosh (Chief Rates Strategist, ASEAN & Korea, Standard Chartered Bank)

    The 4th AMRO Forum runs alongside the ASEAN+3 Finance and Central Bank Deputies’ Meeting, reinforcing the Forum’s positioning as a vital touchstone for policy dialogue and regional cooperation.

    AMRO extends its sincere appreciation to HKMA and BIS for their strong support and cooperation in delivering this successful event.

    For those unable to attend in person, please visit here to watch the AMRO Forum online. Selected opening remarks and keynote speeches will be made available on the AMRO website after the event.

     

    About AMRO

    The ASEAN+3 Macroeconomic Research Office (AMRO) is an international organization established to contribute toward securing macroeconomic and financial stability of the ASEAN+3 region, comprising members of the Association of Southeast Asian Nations (ASEAN) and China; Hong Kong, China; Japan; and Korea. AMRO’s mandate is to conduct macroeconomic surveillance, support regional financial arrangements, and provide technical assistance to the members. In addition, AMRO also serves as a regional knowledge hub and provides support to ASEAN+3 financial cooperation.


    Continue Reading

  • India's stock benchmarks set to open flat after profit booking near record high levels – Reuters

    1. India’s stock benchmarks set to open flat after profit booking near record high levels  Reuters
    2. Indian Markets Retreat As Investors Take Profits Near Highs  Finimize
    3. The SENSEX Index Closes 0.52% Lower  TradingView
    4. Equity indices slip on FII outflows  Times of India
    5. Sensex Falls 331 Points, Nifty Slips Below 26,000 as Markets Decline for Second Day  Deccan Herald

    Continue Reading

  • MHI Receives EPC Contract for Cyclo Olefin Polymer Plant for Zeon Corporation

    MHI Receives EPC Contract for Cyclo Olefin Polymer Plant for Zeon Corporation

    Tokyo, November 25, 2025 – Mitsubishi Heavy Industries, Ltd. (MHI) has been awarded the engineering, procurement, and construction (EPC) contract for a Cyclo Olefin Polymer (COP)(Note) production plant planned by Zeon Corporation (hereinafter “Zeon”) in Shunan City, Yamaguchi Prefecture. The plant is scheduled for completion in the first half of fiscal 2028.

    Leveraging its extensive experience in chemical plant design and construction, MHI will deliver process design, procurement of major equipment, and installation of plant machinery. The architectural and civil engineering works will be undertaken by Fujita Corporation.

    MHI’s proposal was highly evaluated based on its abundant knowledge and expertise in high-performance chemicals.

    MHI is focusing not only on conventional plants such as methanol and ammonia but also on high-performance chemicals including COP. This contract further strengthens MHI’s presence in the domestic and global chemical manufacturing plant markets.

    MHI remains committed to contributing to the advancement of global industry and the realization of a sustainable society through initiatives and products aligned with societal and environmental needs.

    • Cyclo Olefin Polymer (COP) is a high-performance chemical characterized by excellent optical properties, low moisture absorption, and extremely low impurity levels. Demand is expected to grow in optical, medical, and semiconductor applications.

    Continue Reading